title: Update on testis tumours.
abstract: The range of testicular tumours is so large that many pathologists may encounter the rarer variants only a few times, if at all, in their career. This rarity and complexity results in immense challenges for pathologists. For clinicians, due to their rarity and the high cure rate, the difficulty in conducting randomised trials in this area, even in the more common germ cell tumours, means that progress is slow and it is difficult to accumulate evidence for the relevance of the various histopathological risk factors for recurrence. A number of recent trials and retrospective analyses have suggested that some histopathological features suggestive of recurrence are more important than others. This has implications both in how testicular tumours are examined macroscopically and microscopically. New clinically important entities will also be described, as well as some pitfalls in the diagnosis of testicular tumours and how to avoid them.
authors: Centre for Molecular Oncology and Department of Cellular Pathology, Queen Mary University of London, UK. D.Berney@bartsandthelondon.nhs.uk
authors: Daniel M
authors: DM
authors: Berney
mesh_terms: D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology*; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors; D018239:Seminoma / Q000175:diagnosis / Q000473:pathology*; D013736:Testicular Neoplasms / Q000473:pathology*; D013737:Testis / Q000473:pathology*